Vol. 275, Issue 5, L976-L982, November 1998
Sodium hydrosulfite contractions of smooth muscle are calcium
and myosin phosphorylation independent
Ming-Fu
Yu,
Isabelle
Gorenne,
Xiaoling
Su,
Robert S.
Moreland, and
Michael I.
Kotlikoff
Department of Animal Biology, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia, 19104; and Department of
Physiology, Graduate Hospital Research Building, Allegheny University
of the Health Sciences, Philadelphia, Pennsylvania 19146
 |
ABSTRACT |
In an effort to further understand the processes
underlying hypoxic pulmonary vasoconstriction, we examined the
mechanism by which sodium hydrosulfite
(Na2S2O4),
a potent reducing agent and oxygen scavenger, induces smooth muscle
contraction. In rat pulmonary arterial strips, sodium hydrosulfite (10 mM) induced contractions that were 65.9 ± 12.8% of the response to
60 mM KCl (n = 9 segments).
Contractions were not inhibited by nisoldipine (5 µM) or by repeated
stimulation with caffeine (10 mM), carbonyl cyanide
p-(trifluoromethoxy)phenylhydrazone
(10 µM), or cyclopiazonic acid (10 µM), all of which eliminated
responses to contractile agonists. Maximum force generation after
exposure to sodium hydrosulfite was 0.123 ± 0.013 mN in the
presence of 1.8 mM calcium and 0.127 ± 0.015 mN in the absence of
calcium. Sodium hydrosulfite contractions in pulmonary arterial
segments were not due to the generation of
H2O2
and occurred in the presence of chelerythrine (10 µM), which blocked
phorbol ester contractions, and solution hyperoxygenation. Similar
contractile responses were obtained in rat aortic and tracheal smooth
muscles. Finally, contractions occurred in the complete absence of an
increase in myosin light chain phosphorylation. Therefore sodium
hydrosulfite-induced smooth muscle contraction is not specific to
pulmonary arterial smooth muscle, is independent of calcium and myosin
light chain phosphorylation, and is not mediated by either hypoxia or
protein kinase C.
hypoxia; protein kinase C; pulmonary artery; aorta; hypoxic
pulmonary vasoconstriction
 |
INTRODUCTION |
ALTHOUGH HYPOXIC PULMONARY VASOCONSTRICTION has long
been recognized as a unique contractile response of the pulmonary
vasculature of humans and other species, the mechanism by which hypoxia
stimulates smooth muscle contraction is poorly understood. One popular
method by which hypoxia can be simulated experimentally is through the use of the oxygen scavenger sodium hydrosulfite
(Na2S2O4;
also termed sodium dithionite) (3, 17, 18, 21, 27).
However, sodium hydrosulfite is a potent reducing agent known to have
several cellular actions (3), and the precise mechanism by which this compound evokes cellular responses is not known. We have used measurements of isometric tension and myosin light chain (MLC) phosphorylation to examine the mechanism of sodium hydrosulfite-induced tension development in smooth muscle.
The initiation of smooth muscle contraction is widely believed to
require an increase in cytosolic calcium concentration, which activates
calcium- and calmodulin-dependent MLC kinase, resulting in an increase
in MLC phosphorylation. MLC phosphorylation, in turn, activates myosin,
allowing actin-activated myosin ATPase activity and contraction (for
review see Ref. 23). However, an increasing number of observations have
clearly demonstrated that contractions can be initiated by both
calcium- and MLC phosphorylation-independent pathways (for reviews see
Refs. 9 and 28). The primary candidate for regulation of this alternate
contractile pathway is the thin filament-based protein caldesmon (1).
Caldesmon inhibits actin-activated myosin activity, and this inhibition
can be reversed in vitro by either calcium and calmodulin or
phosphorylation (22). The precise mechanism by which disinhibition of
caldesmon occurs and the extent to which this pathway is
physiologically important are currently unknown.
We report here that sodium hydrosulfite contracts smooth muscle in a
calcium- and phosphorylation-independent manner. The induced
contraction is not specific for pulmonary vascular smooth muscle and
appears to bear little similarity to hypoxic vasoconstriction, which is
calcium dependent (for review see Ref. 25). However, sodium
hydrosulfite may be a useful agent in the investigation of the
physiological relevance and mechanism underlying MLC
phosphorylation-independent contractions.
 |
MATERIALS AND METHODS |
Tension measurement. Adult
Sprague-Dawley rats were euthanized by an intramuscular injection (0.1 ml/100 g body wt) of a mixture of xylazine (8.6 mg/ml) and ketamine
(57.1 mg/ml). Smooth muscle segments (~2 × 4 mm) were prepared
from the first branch of the right or left pulmonary artery, thoracic
aorta, or trachea after connective tissues were dissected away under a
microscope. Each segment was mounted in a cuvette of 200-µl volume,
with one end fixed and the other attached to a force transducer
(Scientific Instruments, Heidelberg, Germany). The output from the
transducer was digitized at 2 Hz and recorded on computer disk (Axotape
Software, Axon Instruments, Foster City, CA). HEPES-buffered
Krebs-Henseleit (HKH) solution was continuously perfused
at 37°C, and the tissue was equilibrated for ~40 min. The
tissues were subjected to a passive tension of 0.2-0.3 mN,
which had been previously determined to produce maximal active tension.
During the equilibration period, tissues were stimulated with
high KCl-HKH solution (60 mM KCl; equimolar substitution for NaCl)
several times until a stable contractile response to KCl-HKH solution
was achieved. Peak contractile responses were determined for each
experimental condition and compared with a paired
t-test.
P < 0.05 was considered significant. All values are expressed as means ± SE.
MLC phosphorylation. MLC
phosphorylation levels were determined in strips of rat pulmonary
artery during the basal resting state and after stimulation with 10 mM
sodium hydrosulfite and 110 mM KCl-HKH solution as previously described
(16). Briefly, at appropriate times after stimulation, the tissues were
rapidly frozen by immersion in a dry ice-acetone slurry containing 6% trichloroacetic acid. The frozen strips were slowly thawed, air-dried, and then homogenized in a solution containing 20 mM dithiothreitol, 10% glycerol, and 1% SDS. The ratio of homogenate solution to tissue
was 20 mg wet weight tissue/ml solution. Homogenates were clarified by
centrifugation and subjected to two-dimensional gel electrophoresis,
and the electrophoresed proteins were transferred to 0.2-µm
nitrocellulose membranes (1 A for 3 h at 4°C). The membranes were
incubated in a phosphate-buffered saline solution (PBSS) containing
0.5% Tween 20 and 3% milk protein for 30 min and then overnight in
PBSS containing 0.5% Tween 20, rabbit anti-chicken gizzard MLC
antibody (1:250 dilution), and mouse anti-chicken gizzard tropomyosin
antibody (1:800 dilution). The membranes were then washed extensively
and incubated with the secondary antibodies (anti-rabbit immunoglobulin
G and anti-mouse immunoglobulin G) conjugated to horseradish
peroxidase. Antibody binding to MLC and tropomyosin was visualized by
exposing nitrocellulose membrane to film to detect an enhanced
chemiluminescent reaction (Amersham, Arlington Heights, IL).
Quantitation of MLC phosphorylation levels was performed with a
Molecular Dynamics personal laser densitometer. MLC phosphorylation
levels were calculated by integration of the autoradiographic spot
corresponding to the phosphorylated MLC as a percentage of the total of
both the phosphorylated and unphosphorylated MLCs. The density of the
satellite spots did not change during any experimental protocol and
therefore was not used in the calculation (7, 14, 17). Results are
expressed in moles of Pi per mole of MLC.
Drugs and chemicals. Sodium
hydrosulfite, norepinephrine (NE), caffeine, carbonyl cyanide
p-(trifluoromethoxy)phenylhydrazone (FCCP), and mouse anti-tropomyosin antibody were obtained from Sigma
(St. Louis, MO). Chelerythrine and cyclopiazonic acid (CPA) were
obtained from Calbiochem (La Jolla, CA). All electrophoretic and
immunoblot chemicals were obtained from Bio-Rad Laboratories (Richmond,
CA). All other chemicals were analytic grade or better. Except for
FCCP, all agents were dissolved to desired concentrations in either HKH
solution or calcium-free HKH solution. The composition of HKH solution
was (in mM) 126 NaCl, 10 HEPES (pH 7.4), 11 glucose, 6 KCl, 1 MgCl2, and 2 CaCl2. The calcium-free HKH
solution was identical to regular HKH solution except that
CaCl2 was omitted and 2 mM EGTA
was added. The pH of the sodium hydrosulfite solution was adjusted to
7.4 with NaOH. FCCP was first dissolved in DMSO and then diluted to 10 mM with HKH solution. The final concentration of DMSO in the FCCP
solution was 0.05%, a concentration shown in preliminary studies not
to influence smooth muscle contractions. All chemicals were applied by
perfusion.
 |
RESULTS |
Sodium hydrosulfite contractions in rat pulmonary
artery are calcium independent. The effects of sodium
hydrosulfite on force development in rat pulmonary arterial segments
were examined, and the results are shown in Fig.
1. Preliminary experiments indicated that
when sodium hydrosulfite concentrations < 10 mM were used, contractile responses were variable. Only 56% of tissues examined (n = 9 segments) contracted in
response to 5 mM sodium hydrosulfite. In contrast, 10 mM sodium
hydrosulfite produced reversible and reproducible contractions in all
vascular tissues. As shown in Fig.
1A, the contraction in response to
10 mM sodium hydrosulfite, although slower in rate than that in
response to 60 mM KCl-PBSS, achieved significant levels of
steady-state force. The maximal active force generated in response to
10 mM sodium hydrosulfite was 0.123 ± 0.013 mN
(n = 9 segments), a value equivalent
to 65.9 ± 12.8% of the contraction induced by 60 mM KCl-PBSS (Fig.
1B).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Sodium hydrosulfite
(Na2S2O4)-induced
contraction of rat pulmonary arterial smooth muscle.
A: representative tracing showing
contractile response of pulmonary arterial segments to
KCl-HEPES-buffered Krebs-Henseleit (HKH) solution and
Na2S2O4.
Note reversibility of
Na2S2O4
response. B:
Na2S2O4-induced
contraction is 65.9 ± 12.8% of maximal response to KCl-HKH
solution. Values are means ± SE for 9 arterial segments.
|
|
To determine whether calcium influx through voltage-dependent calcium
channels or calcium release from intracellular stores was involved in
sodium hydrosulfite-induced contractions, we examined the effect of
nisoldipine, caffeine, and CPA on these contractions. After a 30-min
incubation with 5 µM nisoldipine, a solution of 10 mM sodium
hydrosulfite produced a contraction comparable in magnitude to the
response obtained in the absence of the inhibitor (n = 3 segments). Similarly,
incubation with 10 mM caffeine (n = 5)
or 10 µM CPA (n = 2)
elicited a transient muscle contraction due to the release of
intracellular calcium stores, but neither intervention prevented the
subsequent contractile response to sodium hydrosulfite.
Because neither inhibition of extracellular calcium influx through
dihydropyridine-sensitive channels nor depletion of intracellular stores of calcium significantly affected the sodium
hydrosulfite-induced contraction, we examined the effects of complete
calcium removal. Extracellular calcium was removed by simple deletion
of CaCl2 from the HKH solution.
Intracellular calcium was depleted by prolonged incubation in
CaCl2-free HKH solution and
sequential exposure to calcium-releasing stimuli. Figure
2 shows a representative tracing of nine
similar experiments and demonstrates that in normal 1.8 mM
CaCl2-containing HKH solution and
calcium-replete tissue, 60 mM KCl-HKH solution, 10 µM NE, and 10 mM
sodium hydrosulfite all produce contractions. After
removal of extracellular and intracellular calcium, neither KCl-HKH
solution nor NE induced a contraction; however, the contraction in
response to sodium hydrosulfite was unchanged.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Na2S2O4-induced
contractions occur in the absence of extracellular
Ca2+ and after sarcoplasmic
reticulum Ca2+ depletion.
Contractile responses of rat pulmonary arterial segments were obtained
with 60 mM KCl-HKH solution, 10 µM norepinephrine (NE), and 10 mM
Na2S2O4
in presence of normal 1.8 mM
CaCl2-HKH solution. After 1-h
incubation in Ca2+-free HKH
solution, pulmonary arterial segments were reexposed to same
concentrations of KCl-HKH solution, NE, and
Na2S2O4.
Neither KCl-HKH solution nor NE elicited contractions after
Ca2+-free incubation, whereas
contraction in response to
Na2S2O4
was quite similar to that obtained in 1.8 mM
CaCl2-HKH solution. Results are
representative of 9 experiments.
|
|
A similar experimental strategy was pursued with the use of agents that
release or inhibit uptake of intracellular calcium (Fig.
3). Arterial segments were initially
treated with 10 mM caffeine, 10 µM FCCP (a protonophore), or 10 µM
CPA, followed by the sequential addition of all three agents. The
segments were exposed to HKH solution containing 10 mM sodium
hydrosulfite. As shown in Fig. 3, all three compounds (caffeine, FCCP,
and CPA) produced a contraction when added to calcium-replete tissue.
The complete absence of any increase in force development on the second addition of these agents clearly demonstrated complete calcium depletion of the arterial segments. Even after these harsh
calcium-depletion protocols, the sodium hydrosulfite-induced
contraction remained maximal and reversible. The active force generated
in response to 10 mM sodium hydrosulfite in normal and calcium-free HKH
solution was 0.123 ± 0.013 and 0.127 ± 0.015 mN, respectively
(n = 9 segments).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Na2S2O4-induced
contractions of rat pulmonary arterial segments do not require release
of Ca2+ from ryanodine-sensitive
Ca2+ stores or release of
mitochondrial Ca2+.
A: in
Ca2+-containing solutions, release
of mitochondrial Ca2+ by carbonyl
cyanide
p-(trifluoromethoxy)phenylhydrazone
(FCCP; 10 µM) and inhibition of sarcoplasmic reticulum
Ca2+ uptake by cyclopiazonic acid
(CPA; 10 µM) induces transient contractions. Separate experiments are
shown. B: release of
Ca2+ by activation of ryanodine
receptors with caffeine (Caff; 10 mM) produces transient contraction in
Ca2+-containing HKH solution.
However, after 1-h incubation in
Ca2+-free HKH solution, Caff,
FCCP, and CPA produced no contraction, whereas
Na2S2O4
evoked a large contraction in same muscle segment. Results are
representative of 5-9 experiments for each condition.
|
|
Sodium hydrosulfite-induced contractions are not
unique to pulmonary arterial smooth muscle and do not involve hypoxia
or protein kinase C. To determine whether sodium
hydrosulfite-induced contractions were unique to pulmonary arterial
segments, we performed experiments similar to those shown in Fig. 2 in
rat aortic and tracheal smooth muscle strips. The aortic and tracheal
tissues were incubated in a calcium-free HKH solution for 60 min,
during which time they were repeatedly stimulated with either 10 µM
NE (aortic strips) or 50 µM methacholine (tracheal strips) to deplete intracellular stores of calcium. Similar to the results obtained with
pulmonary arterial segments, the addition of 10 mM sodium hydrosulfite
induced significant levels of force that were unaffected by calcium
depletion (Table 1).
View this table:
[in this window]
[in a new window]
|
Table 1.
Contractile response of rat aorta and tracheal smooth muscle to 10 mM
sodium hydrosulfite in presence and absence of calcium
|
|
Because sodium hydrosulfite is an oxygen scavenger, we sought to
determine whether hypoxia was a necessary condition for the observed
calcium-independent contractions described above. As shown in Fig.
4, addition of 10 mM sodium hydrosulfite to
the perfusion chamber contracted rat pulmonary arterial segments and lowered the PO2 of HKH solution from
~140 to <2 mmHg. However, 10 mM hydrosulfite contracted the
pulmonary arterial segments (n = 4) to
a similar degree, even though the solution was continually aerated with
95% O2-5%
CO2 for 30 min so that the
PO2 levels increased to between 200 and 414 mmHg.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
Na2S2O4
contractions are independent of PO2.
Contractile response of rat pulmonary arterial segments to 10 mM
Na2S2O4
was examined under conditions of low
(left) and high
(right)
PO2. Elevated
PO2 (200-414 mmHg) conditions
were produced by aerating HKH solution with 95%
O2-5%
CO2 for ~30 min.
Na2S2O4-induced
contractions were similar at both ranges of
PO2. Tracing is representative of 3 experiments.
|
|
To determine whether the contraction to sodium hydrosulfite results
from the formation of
H2O2,
we tested the effects of
H2O2 on rat pulmonary arterial segments. Consistent with a previous study
(19), the pulmonary segments contracted in response to 1 and 10 mM
H2O2
in normal, calcium-containing HKH solution (Fig. 5). However, neither concentration of
H2O2
contracted segments (n = 3) in
calcium-free HKH solution, although contractions to sodium hydrosulfite
were not affected. These data suggest that generation of
H2O2
is not the mechanism by which sodium hydrosulfite initiates force
development.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Na2S2O4
contractions do not occur by formation of
H2O2.
A:
H2O2
contracted pulmonary arterial segments slightly at 1 mM and more
forcefully at 10 mM in
Ca2+-containing solution.
B: in
Ca2+-free HKH solution, however, 1 and 10 mM
H2O2
failed to produce contractions. In contrast, 10 mM
Na2S2O4
contracted segments in Ca2+-free
solution (see Fig. 2 and Table 1).
|
|
In addition to the widely studied and accepted role of MLC kinase,
protein kinase C-catalyzed protein phosphorylation has been implicated
in contractile regulation and especially in calcium-independent pathways (2, 6). To determine whether protein kinase C is important in
the sodium hydrosulfite-induced contraction, we utilized the protein
kinase C inhibitor chelerythrine (7). We first determined that rat
pulmonary arterial segments contracted in response to the addition of
an activator of protein kinase C, phorbol 12,13-dibutyrate, and that
chelerythrine was capable of inhibiting this contraction. As shown in
Fig. 6A,
exposure of muscle segments to 0.1 µM phorbol 12,13-dibutyrate
produced a large, sustained contraction and this contraction was
completely abolished by pretreatment with 10 µM chelerythrine. For
examination of the role of protein kinase C in sodium hydrosulfite
contractions, calcium-depleted pulmonary arterial segments were
contracted by the addition of 10 mM sodium hydrosulfite, relaxed, and
then incubated in calcium-free HKH solution containing 10 µM
chelerythrine. The calcium-depleted tissues were challenged a second
time with 10 mM sodium hydrosulfite, this time in the presence of
chelerythrine. As shown in the tracing in Fig.
6B (representative of 4 experiments), inhibition of protein kinase C by chelerythrine had no effect on the
sodium hydrosulfite-induced contraction.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Inhibition of protein kinase C does not alter
Na2S2O4-induced
contraction. A: phorbol
12,13-dibutyrate (PDBu) produced a large, sustained contraction of rat
pulmonary arterial segments, which was blocked by preincubation with
chelerythrine (10 µM; right).
B: conversely, contraction of rat
pulmonary arterial segments to 10 mM
Na2S2O4
was not affected by incubation with 10 µM chelerythrine.
|
|
Sodium hydrosulfite-induced contractions are
independent of MLC phosphorylation. The potential
mechanism of sodium hydrosulfite-induced contractions was investigated
by quantifying MLC phosphorylation levels. MLC phosphorylation levels
were measured at rest, at various time points during a 10 mM sodium
hydrosulfite-induced contraction, and at the peak of a KCl-HKH
solution-induced contraction, with both contractions in the presence of
calcium. The results of these experiments are shown in
Fig. 7. MLC phosphorylation levels did not
increase above the basal level at any time point measured during the
sodium hydrosulfite-induced contraction. In contrast, after 3 min of
membrane depolarization by KCl-HKH solution, MLC phosphorylation levels
increased to >0.5 mol Pi/mol
MLC. Therefore, these data clearly demonstrate that the contraction of
pulmonary arterial segments in response to sodium hydrosulfite is
independent of an increase in MLC phosphorylation and must be initiated
by an alternate pathway.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 7.
Na2S2O4
contractions occur in absence of myosin light chain (MLC)
phosphorylation. MLC phosphorylation levels were measured in rat
pulmonary arterial segments during contractions to 10 mM
Na2S2O4
(normal HKH solution). Although
Na2S2O4
produced a significant increase in force, MLC phosphorylation levels
were not elevated above basal value at any time point measured. For
comparison, MLC phosphorylation after 3-min stimulation with 60 mM KCl
is shown. KCl depolarization produced significant increase in MLC
phosphorylation levels. Values are means ± SE;
n = 3 segments.
* P < 0.001 compared
with basal value.
|
|
 |
DISCUSSION |
We report in this study that the oxygen scavenger and reducing agent
sodium hydrosulfite contracts arterial and tracheal smooth muscle
preparations by a mechanism that is not dependent on an increase in
either calcium or MLC phosphorylation. Contractions of the smooth
muscles in response to sodium hydrosulfite were consistently obtained
during conditions in which the muscle segments were repeatedly exposed
to calcium-mobilizing agents until no contraction in response to
standard receptor- or membrane-mediated pathways could be elicited.
Reversible, maximal contractions of the pulmonary artery were obtained
in response to sodium hydrosulfite after calcium depletion, whereas
contractions in response to the addition of NE, caffeine, FCCP, or CPA
were abolished. Moreover, contractions in response to sodium
hydrosulfite were not associated with an increase in MLC
phosphorylation levels, whereas membrane depolarization resulted in a
concomitant increase in force and MLC phosphorylation. The fact that
these calcium- and MLC phosphorylation-independent contractions are
maximal and reproducible suggests that sodium hydrosulfite may be
activating a physiologically relevant regulatory pathway rather than
simply inducing an artifactual conformational change in one or more
contractile proteins.
The two most likely candidates for coupling sodium hydrosulfite
stimulation with a calcium- and MLC phosphorylation-independent contractile event are protein kinase C and hypoxia. The addition of
sodium hydrosulfite to physiological salt solutions has been shown to
result in the generation of superoxide radicals (3). Such radicals have
been shown to activate protein kinase C (4), which has been implicated
in the regulation of smooth muscle contractions (2, 6, 8), including
calcium-independent contractions (6, 11, 12). Moreover, direct
measurements of protein kinase C isoforms in smooth muscle have
provided evidence of a role for calcium-independent isoforms in
contractile regulation (8). We therefore examined the hypothesis that
sodium hydrosulfite contractions resulted from the activation of
protein kinase C. However, the protein kinase C inhibitor chelerythrine
had no effect on sodium hydrosulfite-induced contraction but completely
inhibited phorbol ester-induced contractions (Fig. 6).
Hypoxia produced by the oxygen-scavenging properties of sodium
hydrosulfite also does not appear to be the mechanism underlying the
calcium-independent contraction because hyperoxygenating the sodium
hydrosulfite-containing solution did not abolish the contractions. Moreover, hypoxic pulmonary vasoconstriction is associated with an
increase in cellular calcium (20, 24, 26) and myosin phosphorylation
(14, 29), and hypoxia relaxes systemic vessels such as the aorta,
whereas sodium hydrosulfite-induced, calcium-independent contractions
were obtained in both pulmonary artery and aorta. The conclusion that
hypoxia is not important in the sodium hydrosulfite-induced contraction
raises concerns with respect to the use of this compound as a
convenient agent to generate hypoxic solutions, as previously discussed
by Archer and co-workers (3). The wide variety of chemicals derived
from sodium hydrosulfite, such as superoxide radicals, may confuse or
even mislead the interpretation of the results of experiments based on
this chemical. The generation of
H2O2
by sodium hydrosulfite could not explain the observed calcium-independent contractions, however, because such contractions were blocked by removal of extracellular calcium (Fig. 5).
Our determination that sodium hydrosulfite contractions are calcium
independent relies on the adequacy of the calcium-depletion protocol as
assessed by abolition of receptor-mediated contraction. This appears to
be a reasonable assumption because the depletion protocol effectively
eliminated contractions to NE, caffeine, FCCP, and CPA but had no
effect on sodium hydrosulfite-induced contractions. Moreover, the
absence of increased MLC phosphorylation levels further suggests that
these contractions occur by a fundamentally different mechanism. MLC
phosphorylation values were found to be within the linear range for
densitometric analysis of an autoradiographic spot with enhanced
chemiluminescence, and immunoblot analysis verified the location of the
MLC on the nitrocellulose membrane.
On the basis of the results presented in this study, sodium
hydrosulfite induces smooth muscle contraction by a novel mechanism that is independent of MLC phosphorylation. Although we have no evidence to indicate a specific signaling mechanism, we speculate that
exposure to sodium hydrosulfite either induces a conformational change
in MLC that mimics the effect of phosphorylation or results in a
disinhibition of regulatory thin filaments such as caldesmon. Such an
effect could occur because of a direct action of sodium hydrosulfite,
an action of a metabolite such as bisulfite or bisulfate, or the
generation of a reactive oxygen species other than
H2O2. With respect to the former mechanism, Ikebe et al. (10) suggested that
specific changes in ionic constituents, such as a high
Mg2+ concentration, may contract
smooth muscle by mimicking the phosphorylation-induced conformational
change in MLC. However, such contractions are typically submaximal and
are characterized by a substantially slower rate of force development
(15). With respect to the latter mechanism, Katsuyama et al. (13) have
shown that a peptide that competes for the caldesmon-binding site on
actin but is not inhibitory to myosin ATPase activity induces a
calcium-independent contraction in permeabilized smooth muscle.
Disinhibition of caldesmon may allow expression of an inherent level of
activated myosin that is normally under tonic inhibition by the
caldesmon protein (6, 28). Such disinhibition could occur by a
conformational change in caldesmon produced by sodium hydrosulfite or
its metabolites. Whether the sodium hydrosulfite-induced contraction is
initiated by this mechanism is unknown; however, we are not aware of
any other reported calcium-independent contractile mechanism that could
explain these findings.
In summary, we have demonstrated that stimulation of several smooth
muscles with sodium hydrosulfite produces a reproducible, maximal
contraction that is independent of calcium and MLC phosphorylation levels. The contraction is not dependent on protein kinase C and does
not result from hypoxic conditions. Although no information is
presently available to suggest a mechanism for the contraction, our
results do provide a simple and inexpensive means of initiating calcium- and MLC phosphorylation-independent contractions in smooth muscle, which may facilitate mechanistic studies.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Len Adam for generously providing the rabbit
anti-chicken gizzard myosin light chain antibody.
 |
FOOTNOTES |
This study was funded in part by National Heart, Lung, and Blood
Institute Grants HL-41084, HL-45239 (both to M. I. Kotlikoff), HL-37956, and HL-46704 (both to R. S. Moreland), and a Fellowship from
the Southeastern Pennsylvania Affiliate of the American Heart Association (to I. Gorenne).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: M. I. Kotlikoff, Dept. of Animal Biology,
Univ. of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104-6046.
Received 27 January 1998; accepted in final form 22 July 1998.
 |
REFERENCES |
1.
Allen, B. G.,
and
M. P. Walsh.
The biochemical basis of the regulation of smooth-muscle contraction.
Trends Biochem. Sci.
19:
362-368,
1994[Medline].
2.
Andrea, J. E.,
and
M. P. Walsh.
Protein kinase C of smooth muscle.
Hypertension
20:
585-595,
1992[Abstract/Free Full Text].
3.
Archer, S. L.,
V. Hampl,
D. P. Nelson,
E. Sidney,
D. A. Peterson,
and
E. K. Weir.
Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia.
Circ. Res.
77:
174-181,
1995[Abstract/Free Full Text].
4.
Brawn, M. K.,
W. J. Chiou,
and
K. L. Leach.
Oxidant-induced activation of protein kinase C in UC11MG cells.
Free Radic. Res.
22:
23-37,
1995[Medline].
5.
Coburn, R. F.,
S. Moreland,
R. S. Moreland,
and
C. B. Baron.
Rate-limiting energy-dependent steps controlling oxidative metabolism-contraction coupling in rabbit aorta.
J. Physiol. (Lond.)
448:
473-492,
1992[Abstract/Free Full Text].
6.
Fulginiti, J.,
H. A. Singer,
and
R. S. Moreland.
Phorbol ester-induced contractions of swine carotid artery are supported by slowly cycling crossbridges which are not dependent on calcium or myosin light chain phosphorylation.
J. Vasc. Res.
30:
315-322,
1993[Medline].
7.
Herbert, J. M.,
J. M. Augereau,
J. Gleye,
and
J. P. Maffrand.
Chelerythrine is a potent and specific inhibitor of protein kinase C.
Biochem. Biophys. Res. Commun.
172:
993-999,
1990[Medline].
8.
Horowitz, A.,
O. Clement-Chomienne,
M. P. Walsh,
and
K. G. Morgan.
-Isoenzyme of protein kinase C induces a Ca2+-independent contraction in vascular smooth muscle.
Am. J. Physiol.
271 (Cell Physiol. 40):
C589-C594,
1996[Abstract/Free Full Text].
9.
Horowitz, A.,
C. B. Menice,
R. Laporte,
and
K. G. Morgan.
Mechanisms of smooth muscle contraction.
Physiol. Rev.
76:
967-1003,
1996[Abstract/Free Full Text].
10.
Ikebe, M.,
R. J. Barsotti,
S. Hinkins,
and
D. J. Hartshorne.
Effects of magnesium chloride on smooth muscle actomyosin adenosine-5'-triphosphatase activity, myosin conformation, and tension development in glycerinated smooth muscle fibers.
Biochemistry
23:
5062-5068,
1984[Medline].
11.
Jiang, M. J.,
and
K. G. Morgan.
Intracellular calcium levels in phorbol ester-induced contractions of vascular muscle.
Am. J. Physiol.
253 (Heart Circ. Physiol. 22):
H1365-H1371,
1987[Abstract/Free Full Text].
12.
Jiang, M. J.,
and
K. G. Morgan.
Agonist-specific myosin phosphorylation and intracellular calcium during isometric contractions of arterial smooth muscle.
Pflügers Arch.
413:
637-643,
1989[Medline].
13.
Katsuyama, H.,
C. L. Wang,
and
K. G. Morgan.
Regulation of vascular smooth muscle tone by caldesmon.
J. Biol. Chem.
267:
14555-14558,
1992[Abstract/Free Full Text].
14.
Madden, J. A.,
M. S. Vadula,
and
V. P. Kurup.
Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells.
Am. J. Physiol.
263 (Lung Cell. Mol. Physiol. 7):
L384-L393,
1992[Abstract/Free Full Text].
15.
Moreland, R. S.,
and
S. Moreland.
Characterization of magnesium-induced contractions in detergent-skinned swine carotid media.
Am. J. Physiol.
260 (Cell Physiol. 29):
C1224-C1232,
1991[Abstract/Free Full Text].
16.
Moreland, S.,
J. Nishimura,
C. van Breemen,
H. Y. Ahn,
and
R. S. Moreland.
Transient myosin phosphorylation at constant Ca2+ during agonist activation of permeabilized arteries.
Am. J. Physiol.
263 (Cell Physiol. 32):
C540-C544,
1992[Abstract/Free Full Text].
17.
Pang, L.,
and
C. Eyzaguirre.
Hypoxia affects differently the intracellular pH of clustered and isolated glomus cells of the rat carotid body.
Brain Res.
623:
349-355,
1993[Medline].
18.
Post, J. M.,
C. H. Gelband,
and
J. R. Hume.
[Ca2+]i inhibition of K+ channels in canine pulmonary artery. Novel mechanism for hypoxia-induced membrane depolarization.
Circ. Res.
77:
131-139,
1995[Abstract/Free Full Text].
19.
Rhoades, R. A.,
C. S. Packer,
D. A. Roepke,
N. Jin,
and
R. A. Meiss.
Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle.
Can. J. Physiol. Pharmacol.
68:
1581-1589,
1990[Medline].
20.
Rodman, D. M.,
T. Yamaguchi,
R. F. O'Brien,
and
I. F. McMurty.
Hypoxic contraction of isolated rat pulmonary artery.
J. Pharmacol. Exp. Ther.
248:
952-959,
1989[Abstract/Free Full Text].
21.
Seki, S.,
and
K. T. MacLeod.
Effects of anoxia on intracellular Ca2+ and contraction in isolated guinea pig cardiac myocytes.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H1045-H1052,
1995[Abstract/Free Full Text].
22.
Sobue, K.,
and
J. R. Sellers.
Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.
J. Biol. Chem.
266:
12115-12118,
1991[Free Full Text].
23.
Somlyo, A. P.,
and
A. V. Somlyo.
Signal transduction and regulation in smooth muscle.
Nature
372:
231-236,
1994[Medline].
24.
Wadsworth, R. M.
Vasoconstrictor and vasodilator effects of hypoxia.
Trends Pharmacol. Sci.
15:
47-53,
1994[Medline].
25.
Weir, E. K.,
and
S. L. Archer.
The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels.
FASEB J.
9:
183-189,
1995[Abstract].
26.
Woodmansey, P. A.,
F. Zhang,
K. S. Channer,
and
A. H. Morice.
Effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries.
J. Cardiovasc. Pharmacol.
25:
324-329,
1995[Medline].
27.
Yuan, X. J.,
W. F. Goldman,
M. L. Tod,
L. J. Rubin,
and
M. P. Blaustein.
Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes.
Am. J. Physiol.
264 (Lung Cell. Mol. Physiol. 8):
L116-L123,
1993[Abstract/Free Full Text].
28.
Zhang, Y.,
S. Moreland,
and
R. S. Moreland.
Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways.
Can. J. Physiol. Pharmacol.
72:
1386-1391,
1994[Medline].
29.
Zhao, Y.,
R. A. Rhoades,
and
C. S. Packer.
Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation.
Am. J. Physiol.
271 (Lung Cell. Mol. Physiol. 15):
L768-L774,
1996[Abstract/Free Full Text].
Am J Physiol Lung Cell Mol Physiol 275(5):L976-L982
0002-9513/98 $5.00
Copyright © 1998 the American Physiological Society